Li Xue, Yang Lianrong, Xu Shujun, Tian Yuan, Meng Xin
School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin, 150040 P. R. China.
Cell Mol Bioeng. 2024 Aug 31;17(4):243-261. doi: 10.1007/s12195-024-00816-z. eCollection 2024 Aug.
The bidirectional regulation of macrophages and exosomes provides a meaningful research direction for the treatment of complications arising from both type 1 and type 2 diabetes mellitus. However, there is currently no comprehensive evaluation of the bidirectional regulatory role of macrophages and exosomes in diabetic complications. In this review, we aim to provide the detailed process of the bidirectional regulation mechanism of macrophages and exosomes, and how macrophage-associated exosomes use this mechanism to make it better applied to clinical practice through biotechnology.
Therefore, we summarized the bidirectional regulation mechanism of macrophages and exosomes and the application based on the bidirectional regulation mechanism from two aspects of inflammation and insulin resistance.
As key regulators of the immune system, macrophages are crucial in the progression of diabetic complications due to their significant impact on the regulation of cellular metabolism, inflammation, and insulin sensitivity. Furthermore, exosomes, as innovative mediators of intercellular communication, transport miRNAs, proteins, and various bioactive molecules, influencing the occurrence and progression of diabetic complications through the regulation of inflammation and insulin resistance. The bidirectional regulation between macrophages and exosomes provides a promising pathway for the treatment of diabetic complications aimed at regulating the immune response and improving insulin sensitivity.
Understanding the complexity of the interaction between macrophages and exosomes can advance the treatment of diabetic complications and drug development, and bringing more innovative and effective treatment strategies for diabetic complications.
巨噬细胞与外泌体的双向调节为1型和2型糖尿病并发症的治疗提供了一个有意义的研究方向。然而,目前尚无对巨噬细胞和外泌体在糖尿病并发症中的双向调节作用进行全面评估。在本综述中,我们旨在阐述巨噬细胞和外泌体双向调节机制的详细过程,以及巨噬细胞相关外泌体如何利用这一机制,通过生物技术更好地应用于临床实践。
因此,我们从炎症和胰岛素抵抗两个方面总结了巨噬细胞和外泌体的双向调节机制以及基于该双向调节机制的应用。
作为免疫系统的关键调节因子,巨噬细胞对细胞代谢、炎症和胰岛素敏感性的调节有重大影响,在糖尿病并发症的进展中起关键作用。此外,外泌体作为细胞间通讯的创新介质,运输微小RNA、蛋白质和各种生物活性分子,通过调节炎症和胰岛素抵抗影响糖尿病并发症的发生和发展。巨噬细胞与外泌体之间的双向调节为旨在调节免疫反应和提高胰岛素敏感性的糖尿病并发症治疗提供了一条有前景的途径。
了解巨噬细胞与外泌体之间相互作用的复杂性可以推动糖尿病并发症的治疗和药物开发,并为糖尿病并发症带来更多创新有效的治疗策略。